Literature DB >> 25350554

Incidence, serum IgE and TARC/CCL17 levels in atopic dermatitis associated with other allergic diseases: an update from the Ishigaki cohort.

Satoshi Takeuchi1, Hitokazu Esaki, Norihiro Furusyo, Sayaka Hayashida, Kazuhiko Yamamura, Gaku Tsuji, Masaki Takemura, Jun Hayashi, Masutaka Furue.   

Abstract

Population cohort studies are important for understanding the current status of the target disease and its relation to comorbidity, gender, age, or environmental factors. To better understand atopic dermatitis (AD) and its related diseases, we initiated in 2001 a population cohort study of nursery school children from Ishigaki Island, Okinawa, Japan. The cohort study comprised a dermatologist-based physical examination, questionnaire administration, and blood sample analysis. The mean prevalence of AD was 6.3%. Questionnaire-based bronchial asthma and egg allergy in the children and paternal and sibling AD were statistically significant risk factors for AD. Boys with AD had a high incidence of asthma that was coexistent with a high serum total immunoglobulin E level. Also a high incidence of egg allergy was associated with greater AD severity as assessed by TARC/CCL17.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25350554     DOI: 10.2340/00015555-1989

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  2 in total

Review 1.  The IL-13-OVOL1-FLG axis in atopic dermatitis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Dugarmaa Ulzii; Yen Hai Vu; Makiko Kido-Nakahara; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2019-10-01       Impact factor: 7.397

2.  Associations between Levels of Urinary Oxidative Stress of 8-OHdG and Risk of Atopic Diseases in Children.

Authors:  Pang-Yen Chen; Chien-Wei Chen; Yu-Jang Su; Wen-Han Chang; Wei-Fong Kao; Chen-Chang Yang; I-Jen Wang
Journal:  Int J Environ Res Public Health       Date:  2020-11-06       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.